# Study of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type

> **NCT00104013** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 1455 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** xaliproden (SR57746A)

## Key facts

- **NCT ID:** NCT00104013
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-11
- **Primary completion:** 2007-11
- **Final completion:** 2007-11
- **Target enrollment:** 1455 (ACTUAL)
- **Last updated:** 2008-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00104013

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00104013, "Study of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT00104013. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*